LEADER 02672nas 2200757-a 450 001 9910693427603321 005 20230902161716.0 035 $a(OCoLC)656877412 035 $a(CKB)5470000002395848 035 $a(CONSER)--2010230262 035 $a(OCoLC)995470000002395848 035 $a(EXLCZ)995470000002395848 100 $a20100819a19999999 -a- a 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAndean Trade Preference Act $eimpact on U.S. industries and consumers and on drug crop eradication and crop substitution 210 $aWashington, DC $cU.S. International Trade Commission$d2000- 215 $a1 online resource 225 1 $aUSITC publication 300 $a"Investigation no. 332-352." 300 $a8th report not available online. 311 $a2377-1526 410 0$aUSITC publication. 517 1 $aImpact on U.S. industries and consumers and on drug crop eradication and crop substitution 517 1 $aImpact of the Andean Trade Preference Act 606 $aTariff preferences$zUnited States$vPeriodicals 606 $aDuty-free importation$zUnited States$vPeriodicals 606 $aDrug control$xInternational cooperation$vPeriodicals 606 $aCommercial policy$2fast 606 $aDrug control$xInternational cooperation$2fast 606 $aDuty-free importation$2fast 606 $aInternational economic relations$2fast 606 $aTariff preferences$2fast 607 $aUnited States$xForeign economic relations$zAndes Region$vPeriodicals 607 $aAndes Region$xForeign economic relations$zUnited States$vPeriodicals 607 $aUnited States$xCommercial policy$vPeriodicals 607 $aAndes Region$xCommercial policy$vPeriodicals 607 $aAndes Region$2fast 607 $aUnited States$2fast 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 615 0$aTariff preferences 615 0$aDuty-free importation 615 0$aDrug control$xInternational cooperation 615 7$aCommercial policy. 615 7$aDrug control$xInternational cooperation. 615 7$aDuty-free importation. 615 7$aInternational economic relations. 615 7$aTariff preferences. 676 $a380 712 02$aUnited States International Trade Commission. 801 0$bGPO 801 1$bGPO 801 2$bDOS 801 2$bOCLCQ 801 2$bOCLCF 801 2$bOCLCO 801 2$bDLC 801 2$bGPO 906 $aJOURNAL 912 $a9910693427603321 996 $aAndean Trade Preference Act$93258528 997 $aUNINA LEADER 01953nam 2200373 450 001 9910135283503321 005 20231208073755.0 010 $a0-7381-0613-5 024 7 $a10.1109/IEEESTD.1997.85519 035 $a(CKB)3780000000092063 035 $a(NjHacI)993780000000092063 035 $a(EXLCZ)993780000000092063 100 $a20231208d1997 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aANSI C63.18-1997 $eAmerican National Standard Recommended Practice for an On-site, Ad-Hoc Test Method for Estimating Radiated Electromagnetic Immunity of Medical Devices to Specific Radio Frequency Transmitters /$fInstitute of Electrical and Electronics Engineers 210 1$aPiscataway, NJ, USA :$cIEEE,$d1997. 215 $a1 online resource (32 pages) 330 $aGuidance is provided for health-care organizations in evaluating the radiated RF electromagnetic immunity of their existing inventories of medical devices to their existing inventories of RF transmitters, as well as to RF transmitters that are commonly available. This recommended practice can also be used for newly purchased medical devices and RF transmitters, as well as for pre-purchase evaluation. It applies to medical devices used in health-care facilities and to portable transmitters with a rated power output of 8 W or less. It does not apply to implantable medical devices, transport environments such as ambulances and helicopters, or to RF transmitters. 517 0 $aANSI C63.18-1997 606 $aMedical instruments and apparatus 606 $aElectromagnetic compatibility 615 0$aMedical instruments and apparatus. 615 0$aElectromagnetic compatibility. 676 $a681.761 801 0$bNjHacI 801 1$bNjHacl 906 $aDOCUMENT 912 $a9910135283503321 996 $aANSI C63.18-1997$93647397 997 $aUNINA